Romain Boidot

Romain Boidot

Department of Biology and Pathology of Tumors, Centre Georges-François Leclerc

Affiliated withCentre Georges-François Leclerc

Research Area

Biology

Biography

Romain Boidot has not added Biography.
If you are Romain Boidot and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

Article Total : 1	Year
Publication title	2014

Other Publications

Article	Year
[Implication of alternative splice transcripts of caspase-3 and survivin in chemoresistance]. Bulletin du cancer\| PubMed ID: 15820916	2005
Distinct expression of Survivin splice variants in breast carcinomas. International journal of oncology\| PubMed ID: 16142334	2005
Overexpression of caspase-3s splice variant in locally advanced breast carcinoma is associated with poor response to neoadjuvant chemotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 17020986	2006
Patterns of loss of heterozygosity in breast carcinoma during neoadjuvant chemotherapy. International journal of oncology\| PubMed ID: 17390016	2007
The expression of BIRC5 is correlated with loss of specific chromosomal regions in breast carcinomas. Genes, chromosomes & cancer\| PubMed ID: 18181175	2008
Predictive value of survivin alternative transcript expression in locally advanced breast cancer patients treated with neoadjuvant chemotherapy. International journal of molecular medicine\| PubMed ID: 19148555	2009
Variations in gene expression and response to neoadjuvant chemotherapy in breast carcinoma. Cancer investigation\| PubMed ID: 19479487	2009
Identification of cyclooxygenase-2 as a major actor of the transcriptomic adaptation of endothelial and tumor cells to cyclic hypoxia: effect on angiogenesis and metastases. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 20068092	2010
Lactate influx through the endothelial cell monocarboxylate transporter MCT1 supports an NF-κB/IL-8 pathway that drives tumor angiogenesis. Cancer research\| PubMed ID: 21300765	2011
Apoptosis gene signature of Survivin and its splice variant expression in breast carcinoma. Endocrine-related cancer\| PubMed ID: 21878572	2011
Regulation of monocarboxylate transporter MCT1 expression by p53 mediates inward and outward lactate fluxes in tumors. Cancer research\| PubMed ID: 22184616	2012
A short caspase-3 isoform inhibits chemotherapy-induced apoptosis by blocking apoptosome assembly. PloS one\| PubMed ID: 22216167	2011
Only missense mutations affecting the DNA binding domain of p53 influence outcomes in patients with breast carcinoma. PloS one\| PubMed ID: 23359294	2013
Survivin-3B potentiates immune escape in cancer but also inhibits the toxicity of cancer chemotherapy. Cancer research\| PubMed ID: 23856250	2013
Transcriptional regulation of the survivin gene. Molecular biology reports\| PubMed ID: 24197699	2014
Survivin-3B promotes chemoresistance and immune escape by inhibiting caspase-8 and -6 in cancer cells. Oncoimmunology\| PubMed ID: 24353917	2013
The transcription factor IRF1 dictates the IL-21-dependent anticancer functions of TH9 cells. Nature immunology\| PubMed ID: 24973819	2014
Next-generation sequencing analysis of lung and colon carcinomas reveals a variety of genetic alterations. International journal of oncology\| PubMed ID: 24990411	2014
A generic cycling hypoxia-derived prognostic gene signature: application to breast cancer profiling. Oncotarget\| PubMed ID: 25216520	2014